-
-
-
-
-
-
-
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) PT Lowered to $33 at H.C. Wainwright
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) PT Raised to $15 at H.C. Wainwright
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) PT Raised to $11 at H.C. Wainwright
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) Acquires FDA-Approved Ultra-Rare Disease Product Nitisinone
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
-
1,158,067 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

